These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23037957)

  • 1. Neuropsychological performance and conversion to Alzheimer's disease in early- compared to late-onset amnestic mild cognitive impairment: CREDOS study.
    Ye BS; Seo SW; Lee Y; Kim SY; Choi SH; Lee YM; Kim DH; Han HJ; Na DL; Kim EJ
    Dement Geriatr Cogn Disord; 2012; 34(3-4):156-66. PubMed ID: 23037957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: A five-year longitudinal study.
    Kim SH; Seo SW; Yoon DS; Chin J; Lee BH; Cheong HK; Han SH; Na DL
    Dement Geriatr Cogn Disord; 2010; 29(3):213-23. PubMed ID: 20332639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of Early-Onset
    Tábuas-Pereira M; Baldeiras I; Duro D; Santiago B; Ribeiro MH; Leitão MJ; Oliveira C; Santana I
    Geriatrics (Basel); 2016 Apr; 1(2):. PubMed ID: 31022805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.
    Mah L; Binns MA; Steffens DC;
    Am J Geriatr Psychiatry; 2015 May; 23(5):466-76. PubMed ID: 25500120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    Xie B; Liu Z; Jiang L; Liu W; Song M; Zhang Q; Zhang R; Cui D; Wang X; Xu S
    J Alzheimers Dis; 2017; 55(2):509-520. PubMed ID: 27662297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.
    Bolívar JC; Saladie DG
    J Alzheimers Dis; 2016 May; 53(2):705-12. PubMed ID: 27163821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory complaints in subjective cognitive impairment, amnestic mild cognitive impairment and mild Alzheimer's disease.
    Ryu SY; Lee SB; Kim TW; Lee TJ
    Acta Neurol Belg; 2016 Dec; 116(4):535-541. PubMed ID: 26861053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.
    Cho H; Choi JY; Lee SH; Lee JH; Choi YC; Ryu YH; Lee MS; Lyoo CH
    Neurobiol Aging; 2017 May; 53():103-111. PubMed ID: 28254589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free and Cued Selective Reminding Test is superior to the Wechsler Memory Scale in discriminating mild cognitive impairment from Alzheimer's disease.
    Lemos R; Cunha C; Marôco J; Afonso A; Simões MR; Santana I
    Geriatr Gerontol Int; 2015 Aug; 15(8):961-8. PubMed ID: 25243721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer's disease.
    Lee YM; Park JM; Lee BD; Moon E; Chung YI; Kang CJ
    Dement Geriatr Cogn Disord; 2012; 33(4):240-4. PubMed ID: 22738930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-Life Depression versus Amnestic Mild Cognitive Impairment: Alzheimer's Disease Incidence in 4 Years of Follow-Up.
    Lauriola M; Mangiacotti A; D'Onofrio G; Cascavilla L; Paris F; Ciccone F; Greco M; Paroni G; Seripa D; Greco A
    Dement Geriatr Cogn Disord; 2018; 46(3-4):140-153. PubMed ID: 30199883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Uncinate Fasciculus as a Predictor of Conversion from Amnestic Mild Cognitive Impairment to Alzheimer Disease.
    Hiyoshi-Taniguchi K; Oishi N; Namiki C; Miyata J; Murai T; Cichocki A; Fukuyama H
    J Neuroimaging; 2015; 25(5):748-53. PubMed ID: 25491469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).
    Marra C; Gainotti G; Fadda L; Perri R; Lacidogna G; Scaricamazza E; Piccininni C; Quaranta D
    J Alzheimers Dis; 2016; 50(1):61-70. PubMed ID: 26639965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.
    Müller S; Saur R; Greve B; Melms A; Hautzinger M; Fallgatter AJ; Leyhe T
    Mult Scler; 2013 May; 19(6):799-805. PubMed ID: 23166118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
    Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
    J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.